Sweetener showdown: erythritol vs. aspartame on blood clot risk
NCT ID NCT05967741
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the common sweetener erythritol affects blood clotting and blood vessel health compared to aspartame. Twenty-four adults with a BMI of 27 or higher will drink beverages sweetened with each sweetener for two weeks. Researchers will measure markers of platelet activation and inflammation to see if erythritol poses any risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATELET AGGREGATION, SPONTANEOUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ragle Human Nutrition Research Center, University of California, Davis
RECRUITINGDavis, California, 95616, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.